3 stories mentioning SHA:605199Updated 37d ago
Every FINWIRES story that references SHA:605199, newest first.
Hainan Huluwa Pharmaceutical (SHA:605199) controlling shareholder Hainan Huluwa Investment Development unfroze 17 million shares, according to a Tuesday filing with the Shanghai bourse.Huluwa Investment could use the unfrozen shares for pledging.The shareholder still has 8 million frozen shares.
Hainan Huluwa Pharmaceutical's (SHA:605199) zoledronic acid concentrate for injection obtained a drug registration certificate from China's National Medical Products Administration, according to a Shanghai bourse filing on Saturday.The pharmaceutical company's shares jumped 3% at the close of Monday's trade.The drug is used in combination with standard antitumor therapy for the treatment of skeletal complications in patients with bone metastases from solid tumors and multiple myeloma.
Hainan Huluwa Pharmaceutical's (SHA:605199) pediatric lung heat cough granules won a bid for China's traditional drug procurement program, according to a Thursday filing with the Shanghai bourse.The granules help with lung function and help treat colds, bronchitis, and bronchopneumonia, among other conditions.
